Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Quipt Home Medical Corp.

Healthcare CA QIPT

4.98CAD
0.02(0.40%)

Last update at 2026-03-17T19:59:00Z

Day Range

4.964.99
LowHigh

52 Week Range

1.905.00
LowHigh

Fundamentals

  • Previous Close 4.96
  • Market Cap215.44M
  • Volume41425
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA41.25M
  • Revenue TTM245.36M
  • Revenue Per Share TTM5.67
  • Gross Profit TTM 177.18M
  • Diluted EPS TTM-0.33

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Income before tax -10.33900M -6.65400M -2.69900M 2.21M -9.32900M
Minority interest - - - - -
Net income -10.70100M -6.76300M -2.78400M 4.84M -6.17400M
Selling general administrative 91.86M 89.23M 5.28M 5.49M 47.37M
Selling and marketing expenses 5.62M 5.47M 4.16M 3.63M 2.38M
Gross profit 177.18M 176.99M 163.84M 106.65M 74.18M
Reconciled depreciation - - - - -
Ebit -3.59500M 0.51M 1.09M 10.96M -1.79767M
Ebitda 48.32M 51.07M 55.25M 40.40M 20.69M
Depreciation and amortization 51.92M 50.55M 54.16M 29.44M 22.49M
Non operating income net other - - - - -
Operating income -3.82300M 1.11M 15.09M 4.73M -1.46000M
Other operating expenses 345.81M 244.80M 206.56M 122.06M 95.72M
Interest expense 12.63M 7.17M 6.61M 2.08M 1.85M
Tax provision - 0.11M - -1.90400M -3.15500M
Interest income - 6.65M - 1.83M 4.28M
Net interest income - - - - -
Extraordinary items - - - - 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.34M 0.11M 0.09M -1.90400M -3.15500M
Total revenue 343.09M 245.91M 221.74M 139.86M 102.35M
Total operating expenses 181.00M 175.88M 148.67M 88.85M 67.54M
Cost of revenue 68.18M 68.92M 57.90M 33.21M 28.17M
Total other income expense net -6.51600M -7.76900M -11.27000M -13.50700M -13.97200M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - -6.76300M - 4.84M -6.17400M
Preferred stock and other adjustments - - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total assets 425.45M 247.25M 247.41M 132.21M 108.57M
Intangible assets 107.92M 67.95M 74.04M 28.89M 14.87M
Earning assets - - - - -
Other current assets 17.13M - 3.83M - -
Total liab 269.48M 140.06M 136.29M 52.67M 49.95M
Total stockholder equity 139.69M 107.19M 111.11M 79.55M 58.62M
Deferred long term liab - - - - -
Other current liab 37.66M - -27.09900M - -
Common stock - 0.00000M 247.53M 214.25M 203.48M
Capital stock - - - - -
Retained earnings -252.22186M -170.57100M -163.80800M -161.02400M -165.86300M
Other liab - - - - -
Good will 85.65M 50.73M 52.83M 28.21M 12.46M
Other assets - 0.34M - 0.09M 0.50M
Cash 17.97M 16.17M 17.21M 8.52M 34.61M
Cash and equivalents - - - - -
Total current liabilities 103.95M 60.85M 60.57M 41.74M 32.74M
Current deferred revenue 4.59M - 4.51M - -
Net debt 147.32M - 80.75M - -
Short term debt 23.27M 0.00000M 22.59M 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total 118.79M - 97.96M - -
Other stockholder equity 391.91M - 27.39M - -
Property plant equipment - 53.86M - 33.50M 23.51M
Total current assets 109.01M 73.05M 65.43M 41.54M 57.23M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 48.28M 29.12M 48.22M 16.38M 11.94M
Long term debt - 64.60M - 3.73M 12.30M
Inventory 25.64M 20.85M 18.41M 15.59M 9.25M
Accounts payable 38.43M - 60.57M - -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 57.04M - 1.71M - -
Deferred long term asset charges - - - - -
Non current assets total 316.43M - 181.97M - -
Capital lease obligations - - - - -
Long term debt total - 77.88M - 10.93M 17.08M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities -46.06759M -10.31300M - -42.49300M -17.83800M
Net borrowings - - - - -
Total cash from financing activities -10.84815M -26.14700M 50.87M -9.85100M 3.91M
Change to operating activities - - - - -
Net income -10.70100M -6.76300M -2.78400M 4.84M -6.17400M
Change in cash -3.87894M -1.03500M 8.69M -26.09600M 5.38M
Begin period cash flow 21.85M 17.21M 8.52M 34.61M 29.23M
End period cash flow 17.97M 16.17M 17.21M 8.52M 34.61M
Total cash from operating activities 52.71M 35.38M 40.54M 26.34M 18.69M
Issuance of capital stock - - - - -
Depreciation 51.92M 50.55M 40.16M 23.04M 17.79M
Other cashflows from investing activities -11.88959M 0.21M - -33.33200M -12.79200M
Dividends paid - - - - -
Change to inventory -3.37974M -3.42000M -0.06000M -2.41900M -0.04400M
Change to account receivables 3.60M -3.29400M -3.06300M -0.20100M -8.82500M
Sale purchase of stock -0.18178M 0.57M -1.81733M 0.57M 19.08M
Other cashflows from financing activities -0.11047M -0.64900M 63.42M 10.79M 17.80M
Change to netincome - - - - -
Capital expenditures 17.27M 10.31M 6.79M 8.97M 5.05M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.51298M -7.65400M -1.94900M 0.76M -8.87600M
Stock based compensation 4.04M 2.48M 5.28M 5.49M 4.95M
Other non cash items 8.88M -3.58300M -0.25900M -5.88200M 14.80M
Free cash flow 35.43M 25.07M 33.75M 17.38M 13.65M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
QIPT
Quipt Home Medical Corp.		 0.02 0.40% 4.98 - 56.50 0.88 1.57 1.07 5.46

Reports Covered

Stock Research & News

View All

Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aids, power mobility, respiratory equipment rental, oxygen therapy services. It also provides solutions that supports patients dealing with heart and pulmonary disease, reduced mobility, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Quipt Home Medical Corp.

1019 Town Drive, Wilder, KY, United States, 41076

Key Executives

Name Title Year Born
Mr. Gregory J. Crawford Chairman, President & CEO NA
Mr. Hardik Mehta Chief Financial Officer NA
Mr. David Bachelder Executive Vice President of Operations NA
Mr. William Todd Zehnder Chief Strategy Officer & Investor Relations 1975
Cole Stevens VP of Corporate Development & VP of Investor Relations NA
Mr. Mark Miles Vice President of Information Technology NA
Mr. Thomas W. Roehrig Executive Vice President of Finance 1966
Patrick Dennis Gamble Executive Vice President of Operations NA
Mr. Robert Grossman LLB Corporate Secretary 1974
Mr. Gregory J. Crawford Chairman, President & CEO 1974

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.